scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
scPharmaceuticals (Nasdaq: SCPH) announced it will release its third quarter 2024 financial results on Wednesday, November 13, 2024. The company will host a conference call and audio webcast at 4:30 p.m. ET on the same day to discuss financial results and provide a business update. Participants can join via phone using domestic (1-877-407-9208) or international (1-201-493-6784) numbers with conference code 13749995. A webcast and replay will be available through the company's website.
scPharmaceuticals (Nasdaq: SCPH) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 mercoledì 13 novembre 2024. L'azienda ospiterà una conferenza telefonica e un webcast audio alle 16:30 ET dello stesso giorno per discutere i risultati finanziari e fornire un aggiornamento sull'azienda. I partecipanti possono unirsi telefonicamente utilizzando numeri nazionali (1-877-407-9208) o internazionali (1-201-493-6784) con il codice conferenza 13749995. Un webcast e una registrazione saranno disponibili attraverso il sito web dell'azienda.
scPharmaceuticals (Nasdaq: SCPH) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el miércoles 13 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica y una transmisión de audio a las 4:30 p.m. ET el mismo día para discutir los resultados financieros y proporcionar una actualización sobre el negocio. Los participantes pueden unirse por teléfono utilizando números nacionales (1-877-407-9208) o internacionales (1-201-493-6784) con el código de conferencia 13749995. Una transmisión y una repetición estarán disponibles a través del sitio web de la compañía.
scPharmaceuticals (Nasdaq: SCPH)는 2024년 11월 13일 수요일에 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 재무 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 전화 회의 및 오디오 웹캐스트를 진행합니다. 참가자는 국내 전화번호 (1-877-407-9208) 또는 국제 전화번호 (1-201-493-6784)를 사용하여 13749995 회의 코드를 입력하여 참여할 수 있습니다. 회사 웹사이트를 통해 웹캐스트 및 재생이 제공됩니다.
scPharmaceuticals (Nasdaq: SCPH) a annoncé qu'elle publiera ses résultats financiers pour le troisième trimestre 2024 le mercredi 13 novembre 2024. La société organisera une conférence téléphonique et un webcast audio à 16h30 ET le même jour pour discuter des résultats financiers et fournir une mise à jour sur l'entreprise. Les participants peuvent rejoindre par téléphone en utilisant les numéros nationaux (1-877-407-9208) ou internationaux (1-201-493-6784) avec le code de conférence 13749995. Un webcast et un replay seront disponibles sur le site web de l'entreprise.
scPharmaceuticals (Nasdaq: SCPH) gab bekannt, dass es am Mittwoch, den 13. November 2024, seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Audiowebcast abhalten, um die Finanzergebnisse zu erörtern und ein Unternehmensupdate zu geben. Die Teilnehmer können sich telefonisch über nationale (1-877-407-9208) oder internationale (1-201-493-6784) Nummern mit dem Konferenzcode 13749995 einwählen. Ein Webcast und eine Wiederholung werden über die Website des Unternehmens verfügbar sein.
- None.
- None.
Management to host conference call and webcast, after-market on November 13, 2024, at 4:30 p.m. ET
BURLINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, November 13, 2024, to discuss the financial results for the third quarter 2024 and provide a business update.
Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13749995.
To access the new Call me feature, which avoids having to wait for an operator, click here.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com
FAQ
When will scPharmaceuticals (SCPH) report Q3 2024 earnings?
How can I join scPharmaceuticals (SCPH) Q3 2024 earnings call?
What time is scPharmaceuticals (SCPH) Q3 2024 earnings call?
